Skip to content

Influence of Sex Hormones on the Biomechanics and Injuries of the Lower Extremities in Female Recreational Athletes

Influence of Sex Hormones on the Biomechanics and Injuries of the Lower Extremities in Female Recreational Athletes - FeHBI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035056
Enrollment
212
Registered
2024-09-12
Start date
2024-09-06
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

S93.2 M23.61

Interventions

Group 1: Longitudinal observation with simultaneous measurement of the hormone profile and biomechanics during functional assessments at 4 points in the menstrual cycle and during 2 menstrual cycles.

Sponsors

ZHAW Zürcher Hochschule für Angewandte Wissenschaften
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 34 Years

Inclusion criteria

Inclusion criteria: - Recreational athletes with 3-10 hours of exercise per week - Eumenorrheic: self-reported cycle length between 24 and 35 days resulting in at least 9 periods per year or users of non-hormonal (copper) intrauterine contraceptive devices - No injuries requiring medical attention or rehabilitation during the last 6 months - Able to perform jumping, hopping, and cutting movements - Body mass index < 28 kg/m2 - Willingness to apply the TAP®-Device for minimally invasive blood analysis - Ability to give informed consent

Exclusion criteria

Exclusion criteria: - Complete rupture of ligaments in the lower extremities - Surgical reconstruction of ligaments in the lower extremities - Pregnancy or breast feeding - Acute or chronic diseases (neurological, cardiopulmonary, musculoskeletal, untreated endocrinologic disorders) - Use of systemic effective hormonal contraceptives such as combined contraceptives (pill, vaginal ring, transdermal patch), progestin-only preparations, or long-acting reversible contraceptives (implants, injections) or non-systemic intrauterine hormonal devices (IUD) - Any kind of hormone replacement therapy (transdermal or peroral) in the past 3 months - Any kind of anti-hormonal therapy (e.g. letrozole, tamoxifen)

Design outcomes

Primary

MeasureTime frame
Biomechanical variables related to acute ligamentous lower extremity injuries: - peak hip flexion angles - peak knee flexion, abduction, internal rotation angles - peak knee flexion and abduction moments - peak ankle plantarflexion, dorsiflexion, inversion angles - ankle dorsiflexion/plantarflexion and eversion/inversion range of motion - peak ankle inversion velocity - peak ankle plantarflexion and internal rotation moments - static and dynamic postural balance Muscle activity of: - M. gastrocnemius medialis and lateralis - M. peroneus longus - M. semitendinosus - M. biceps femoris - M. gluteus medius - M. vastus medialis und lateralis Hormonal concentrations of: - FSH - LH - Estrogen - Progesterone - Testosterone - DHEAS-S - Cortisol - 17-H-OP - Prolactin - TSH - AMH primary outcomes will be recorded 8 times (4 times during menstrual cycle, during 2 menstrual cycles) Biomechanical primary outcomes will be recorded using marker-based motion tracking and surface electromyography Hormonal levels will be recorded using blood serum collected using the TAP-Device

Secondary

MeasureTime frame
Influence of biomechanics of functional assessments and hormonal profile on ligamentous lower extremity injuries: participants will be followed longitudinally and in the event of a ligamentous lower extremity injury their data from the primary outcome will be compared to the participants who did not sustain an injury Injury mechanisms of ligamentous lower extremity injuries: after sustaining an injury, all information available on the injury mechanism (interview with participants, observations of bystanders, review of video material if available) will be collected and analyzed

Countries

Switzerland

Contacts

Public ContactEveline Graf

ZHAW Zürcher Hochschule für Angewandte Wissenschaften

eveline.graf@zhaw.ch+41 58 934 64 80

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026